Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Asahi Kasei A Bpep"

05:16 EDT 23rd April 2014 | BioPortfolio

Matching Channels

None

Matching News

RaQualia and Asahi Kasei Pharma progress their collaboration

RaQualia Pharma says that its ongoing joint research with fellow Japanese drugmaker Asahi Kasei Pharma has moved to a new phase. Following the positive results from the collaborative research under th...

Asahi Kasei Zoll Medical receives Japanese approval for X Series monitor/defibrillator

Asahi Kasei Zoll Medical, the Japanese subsidiary of Zoll Medical, has obtained Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its X Series monitor/defibrillator,...

Asahi Kasei Pharma, RaQualia deal

Actelion, Asahi Kasei Pharma cardiovascular news

US Court upholds damages award in Actelion/Asahi litigation

Switzerland-based Actelion says that the California Supreme Court has denied the firm’ petition for review of the Court of Appeal's decision affirming the final judgment entered against Actelion in...

Actelion, Asahi Kasei Pharma, Washington Legal Foundation cardiovascular news

What Competition? Actelion Loses Case Over Stifling A Rival Drug

For the second time this year, Actelion has been tagged for questionable behavior toward rivals. In the latest instance, a California state court judge has upheld a $407 million jury...

Court of Appeal affirms jury award for Asahi

The California Court of Appeal for the first appellate district affirmed a 2011 amended final judgment awarding Asahi Kasei Pharma Corp. (Tokyo, Japan) $407.3 million from Actelion Ltd. (SIX:ATLN) rel...

Matching PubMed Articles

Intravitreal fasudil combined with bevacizumab for treatment of refractory diabetic macular edema; a pilot study.

To evaluate the effect of intravitreal injection of a Rho-associated protein kinase (ROCK) inhibitor (Fasudil, Asahi Kasei Pharma Corporation, Tokyo, Japan) combined with intravitreal bevacizumab (IVB...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement